...ElsaLys Biotech S.A.S., Lyon, France Empirica Therapeutics Inc., Hamilton, Canada Genkyotex S.A. (Euronext:GKTX), Saint-Julien-en-Genevois, France HEC Pharm Group...

...has the small molecule FLT3 inhibitor FF-10101 (FF-10101-01) in Phase I/II testing to treat AML. HEC Pharm Group...

...development since then -- anti-Axl kinase mAb BGB149 from BerGenBio ASA (OSE:BGBIO) and CT413 from HEC Pharm Group...

...FLT3, in Phase I/II testing; Fujifilm Holdings Corp. has FF-10101 in Phase I/II testing; and HEC Pharm Group...

...in Phase I/II testing; Fujifilm Holdings Corp. has FF-10101 in Phase I testing ; and HEC Pharm Group...

...month. HEC Pharm Group , Dongguan, China TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157), Taipei, Taiwan Business: Infectious Nora Weintraub DAG-181 NS5A inhibitor TG-2349 HEC Pharm Group TaiGen...

...Biopharmaceuticals Holdings Ltd. (TPex:4157) and the YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558) subsidiary of HEC Pharm Group...